Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025

United Lincolnshire Teaching Hospitals NHS Trust · awarded 16 January 2025

£106k Award value £105,600
1 Supplier Recorded as a large business
31 Dec 2025 Runs until from 1 Jan 2025

Who

BuyerUnited Lincolnshire Teaching Hospitals NHS Trust Lincoln
Supplier Bayer Public Limited Company
Categorygoods
ClassificationPharmaceutical products CPV 33600000
Notice published24 January 2025

What it is for

Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.

Read the original award notice on Contracts Finder →

Other contracts from this buyer

333 awards on file, worth £243.7m.

Everything United Lincolnshire Teaching Hospitals NHS Trust has awarded →

Other contracts won by this supplier

7 awards on file, worth £528k.

Everything Bayer Public Limited Company has won →